AbbVie Inc 10-K for FY2023
AbbVie Inc. (ABBV)
10-K
2024-02-20
For: 2023-12-31
View Original
Added on
April 02, 2026
About this 10-K
AbbVie Inc filed this 10-K on February 20, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $54.32B
- down 6.4% from $58.05B a year earlier
- Net income
- $4.86B
- down 58.9% from net income of $11.84B a year earlier
- Diluted EPS
- $2.72
- down 59.0% from $6.63 a year earlier